Latest Breaking News On - Daniellem brander - Page 1 : comparemela.com

Danielle M. Brander, MD, discusses the primary analysis of the phase 1/2 TRANSCEND CLL 004 trial in patients with relapsed/refractory chronic lymphocytic leukemia or small lymphocytic lymphoma.

Daniellem branderDuke healthDuke cancer instituteHematologic malignanciesCellular therapyInternational workshop on cllOnclive tv